- Associated Press - Tuesday, February 21, 2012

NEW BRUNSWICK, N.J. (AP) - Johnson & Johnson’s longtime CEO, Bill Weldon, is retiring this April, following an embarrassing string of product recalls that has stretched for more than 2 years, costing the health care giant hundreds of millions of dollars and consumer trust.

The maker of Band-Aids and biotech drugs says Weldon will remain chairman of the board for the time being, while ceding the chief executive post to Alex Gorsky, head of the medical device and diagnostics business.

Weldon, 63, became chief executive in 2002. He’s spent his entire career at the company.

But his tenure has been tarnished since an astounding string of more than two dozen recalls of nonprescription Tylenol, Motrin, Benadryl and other drugs began in 2009. Medical devices and consumer products also have been recalled.

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More and View Comments

Click to Hide